First Opinion Elizabeth Weaver II and Kiana Jackson Disabled scientists are often left out of academia. The NIH can help change that
First Opinion Joshua Mezrich Too many donor organs go to waste. Here’s how to get them into the patients who need them
First Opinion Christopher M. Worsham and Anupam B. Jena Clogged arteries: the unseen cost of road-blocking protests
Business Brittany Trang STAT Plus: Could private equity be the future of private practice? A new lobbying group thinks so
Special Report Sarah Owermohle HHS’s Xavier Becerra, once an ‘invisible’ secretary, is racing to cement a clearer legacy
First Opinion Maggie Hassan STAT Plus: Sen. Maggie Hassan on what Congress must do next to fight the opioid crisis
First Opinion Catherine Ames Being a chronically ill young adult is hard enough. Finding information about my fertility is even harder
First Opinion Barron H. Lerner Remembering Betty Rollin, who told her breast surgeon that post-operative appearance mattered to her — and other women
First Opinion Shannon Smith-Bernardin Sobering centers offer a safe place to recover from intoxication. Every community should have one
First Opinion Romila Santra U.S. medical schools aren’t teaching future doctors about 7.4 million of their patients
Morning Rounds Elizabeth Cooney STAT Plus: STAT Health News: Abortion ‘companion networks,’ NEJM’s racist past, and other stories you need to read
Biotech Rachel Cohrs Zhang STAT Plus: BIO selects rare disease advocate, biotech executive John Crowley as new CEO
Politics Nicholas Florko STAT Plus: Tanden, Becerra, Califf make time for a meeting with tobacco lobbyists on the menthol ban
Pharmalot Ed Silverman STAT Plus: Vertex pushes a donation program to widen access to cystic fibrosis treatments, but advocates say it’s not enough